These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11146252)

  • 41. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
    Pfaller MA; Segreti J
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
    J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.
    Jett BD; Ritchie DJ; Reichley R; Bailey TC; Sahm DF
    Antimicrob Agents Chemother; 1995 May; 39(5):1187-90. PubMed ID: 7625813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ; Rojtman A; Tran K
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
    Pitout JD; Hossain A; Hanson ND
    J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
    Kjerulf A; Hansen DS; Sandvang D; Hansen F; Frimodt-Møller N
    APMIS; 2008 Feb; 116(2):118-24. PubMed ID: 18321362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-β-lactamase-producing Escherichia coli.
    Rhodes NJ; Richardson CL; Heraty R; Liu J; Malczynski M; Qi C; Scheetz MH
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3757-61. PubMed ID: 24752253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of extended- spectrum beta-lactamase producing Escherichia coli and Klebsiella spp in a neonatal intensive care unit.
    Anandan S; Thomas N; Veeraraghavan B; Jana AK
    Indian Pediatr; 2009 Dec; 46(12):1106-7. PubMed ID: 20061592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
    Hupková M; Blahová J; Babálová M; Krcméry V; Králiková K
    J Chemother; 1995 Feb; 7(1):16-20. PubMed ID: 7629551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [[Evaluation of four methods for the detection of ESBL-producing enterobacteria]].
    Acosta-Pérez G; Rodríguez-Abrego G; Castro-Mussot ME
    Salud Publica Mex; 2018; 60(1):106-107. PubMed ID: 29689671
    [No Abstract]   [Full Text] [Related]  

  • 54. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain.
    Hernández JR; Martínez-Martínez L; Cantón R; Coque TM; Pascual A;
    Antimicrob Agents Chemother; 2005 May; 49(5):2122-5. PubMed ID: 15855544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
    Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals.
    Bialvaei AZ; Kafil HS; Asgharzadeh M; Aghazadeh M; Yousefi M
    Braz J Microbiol; 2016; 47(3):706-11. PubMed ID: 27268117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.
    Bhavnani SM; Ambrose PG; Craig WA; Dudley MN; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):231-6. PubMed ID: 16423491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
    Nath R; Saikia L; Mahanta J
    Indian J Pathol Microbiol; 2006 Oct; 49(4):623-5. PubMed ID: 17183880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.